Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China · Delayed Price · Currency is CNY 18.14
+0.10 (0.55%)
Apr 29, 2026, 3:04 PM CST
SHE:300119 Market Cap
SHE:300119 has a market cap or net worth of 8.19 billion as of April 29, 2026. Its market cap has decreased by -1.69% in one year.
Market Cap
8.19B
Enterprise Value
8.50B
Revenue
3.40B
Ranking
n/a
PE Ratio
20.88
Stock Price
18.14
Market Cap Chart
Since September 17, 2010, SHE:300119's market cap has increased from 5.87B to 8.19B, an increase of 39.47%. That is a compound annual growth rate of 2.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 8.24B | -3.36% |
| Dec 31, 2025 | 8.52B | 0.62% |
| Dec 31, 2024 | 8.47B | 11.83% |
| Dec 29, 2023 | 7.57B | -12.26% |
| Dec 30, 2022 | 8.63B | -22.90% |
| Dec 31, 2021 | 11.20B | 48.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 8.55B |
| Shandong Lukang Pharmaceutical | 8.46B |
| Hunan Er-Kang Pharmaceutical | 8.44B |
| Jiuzhitang | 8.31B |
| Sichuan Huiyu Pharmaceutical | 8.20B |
| Guilin Sanjin Pharmaceutical | 8.20B |
| Frontier Biotechnologies | 8.05B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 8.05B |